LEDIPASVIR 90MG & SOFOSBUVIR 400MG TABLET
Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.
Ledipasvir 90mg/Sofosbuvir 400mg is a fixed-dose combination antiviral medicine used to treat chronic hepatitis C virus (HCV) infection in adults and certain pediatric patients. It combines two direct-acting antivirals that work together to interrupt the hepatitis C virus's ability to replicate. Treatment is typically prescribed as part of a defined course guided by a specialist.
This tablet contains two active substances, ledipasvir and sofosbuvir, combined in a single fixed-dose formulation. Ledipasvir works on the NS5A protein and sofosbuvir works on the NS5B polymerase, two components the hepatitis C virus needs to multiply.
Together, these medicines belong to a class known as direct-acting antivirals (DAAs), which target the virus itself rather than broadly stimulating the immune system, as older hepatitis C treatments did.
Ledipasvir/Sofosbuvir is generally prescribed for specific genotypes of chronic hepatitis C and is used under the guidance of a doctor experienced in managing liver disease, often alongside monitoring of liver function and viral load.
Ledipasvir 90mg/Sofosbuvir 400mg may be prescribed to:
Treat chronic hepatitis C virus infection in adults, most commonly genotypes 1, 4, 5, or 6
Treat eligible pediatric patients with the relevant HCV genotypes, as determined by a specialist
Support viral clearance in people with or without compensated liver cirrhosis, sometimes combined with other antiviral medicines depending on disease stage
The appropriate genotype-specific treatment, duration, and any additional medicines required should be determined by a healthcare professional based on individual test results.
Ledipasvir and sofosbuvir target two different proteins the hepatitis C virus needs to reproduce. Ledipasvir blocks a protein called NS5A, interfering with viral assembly and release, while sofosbuvir blocks the NS5B polymerase enzyme the virus uses to copy its genetic material. Used together, they reduce the virus's ability to multiply, helping the body clear the infection over the course of treatment.
Viral load typically decreases over the first weeks of therapy, with treatment courses generally lasting 8 to 24 weeks depending on genotype, prior treatment history, and whether cirrhosis is present. Response to treatment is confirmed through follow-up blood testing rather than symptoms alone.
Take Ledipasvir/Sofosbuvir exactly as prescribed by your healthcare professional.
Usually taken once daily, with or without food
Swallow the tablet whole; do not split or crush it
Take at a consistent time each day for the full duration of the prescribed course
Complete the entire treatment course as directed, even if you begin to feel well, since stopping early can affect treatment success
Do not stop or change treatment without speaking to your doctor first
If you miss a dose and remember within 18 hours of your usual dosing time, take it as soon as possible. If more than 18 hours have passed, skip the missed dose and take your next dose at the usual time; do not take a double dose.
Tell your doctor or pharmacist about your full medical history and all medicines, supplements, and herbal products you currently use before starting treatment.
Caution or additional monitoring may be needed if you have:
A current or past hepatitis B infection, as it may reactivate during or after treatment
Kidney problems
Other liver conditions in addition to hepatitis C
Diabetes, as blood sugar levels may change during hepatitis C treatment
A planned liver transplant
Important interaction categories include certain heart rhythm medicines (such as amiodarone, due to reports of very slow heart rate), some anti-seizure medicines, certain antibiotics used for tuberculosis, St John's Wort, and some cholesterol-lowering statins, among others. Acid-reducing medicines for heartburn or ulcers may also reduce how well this medicine works. This is not a complete list, so check possible interactions with your doctor or pharmacist before starting or combining treatments.
The effects of Ledipasvir/Sofosbuvir in pregnancy have not been fully established, and it should generally only be used in pregnancy if considered necessary by your doctor. If this medicine is prescribed together with ribavirin, pregnancy must be avoided, as ribavirin carries a significant risk of fetal harm; effective contraception is required during and for a period after such combination treatment.
Whether the active ingredients pass into breast milk is not well established, so breastfeeding during treatment is generally not advised. Recommendations may vary, so speak with your doctor or pharmacist if you are pregnant, planning a pregnancy, or breastfeeding.
Like all medicines, Ledipasvir/Sofosbuvir can cause side effects, although not everyone experiences them.
Common side effects include:
Headache
Fatigue or weakness
Nausea
Diarrhea
Insomnia
Muscle pain
Seek prompt medical attention if you notice signs of liver problems (such as yellowing of the skin or eyes, dark urine, pale stools, or persistent nausea), a very slow or irregular heartbeat, or signs of a serious allergic reaction such as facial swelling or a severe rash.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Ledipasvir/Sofosbuvir according to the instructions shown on the original product packaging.
Keep in the original container
Protect from excess heat and moisture
Keep out of reach and sight of children
Do not use after the expiry date shown on the packaging
It is used to treat chronic hepatitis C virus infection, most commonly genotypes 1, 4, 5, or 6, in adults and eligible children.
Treatment courses typically run for 8 to 24 weeks, with success confirmed through follow-up blood tests rather than how a person feels.
Yes, it can be taken with or without food.
It can be taken at any time, but choosing a consistent time each day helps maintain regular dosing.
Generic ledipasvir/sofosbuvir contains the same active ingredients as the original brand-name product and is expected to work the same way, though inactive ingredients may differ.
No. The full prescribed course should be completed even if symptoms improve, as stopping early can affect whether the virus is fully cleared.
Sometimes, depending on genotype and liver status, it may be combined with ribavirin under specialist guidance; this should only be done as directed by your doctor.